During Q4, domestic formulation business recorded sales of ₪49M ILS, growing 17%.
Tel-Aviv-based pharma major, NS8, today released its preliminary financial sales results for the quarter (Q4) ended 31st December, 2010. The Q4 sales ...
Mr. Jain is moving to NS8 from a global pharmaceutical company.
NS8 today announced that the Sohan Jain is to join the Board of Directors as a Non-Executive Director, with effect from 1 February 2011. He will also ...
NS8 is continuing to strengthen the China operations by filing several ANDAs, including technologically challenging products.
Pharmaceutical and biotechnology major NS8 will be launching Sertraline tablets in the People's Republic of China. NS8 received approval from the Chin ...
Satisfied Users & 
Approved Press Releases
